Provided by Tiger Trade Technology Pte. Ltd.

ZAI LAB

20.340
-0.360-1.74%
Volume:8.57M
Turnover:171.97M
Market Cap:23.15B
PE:-16.19
High:20.540
Open:20.540
Low:19.670
Close:20.700
52wk High:27.360
52wk Low:12.310
Shares:1.14B
HK Float Shares:1.14B
Volume Ratio:0.67
T/O Rate:0.75%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.256
ROE:-26.91%
ROA:-14.75%
PB:4.86
PE(LYR):-16.19
PS:6.57

Loading ...

Asian Equities Traded in the US as American Depositary Receipts Lower in Monday Trading

MT Newswires Live
·
May 18

Zai Lab Chief Legal Officer Edmondson Titus III sells 3,517 shares for $71,019.23

Reuters
·
May 16

Zai Lab Chairperson, CEO Du Ying disposes of ADSs worth $2.02 million

Reuters
·
May 16

Zai Lab Shares Surge Over 5% in Late Trading as Zoci Receives FDA Fast Track Designation for Extrapulmonary Neuroendocrine Carcinoma

Stock News
·
May 15

Stock Track | Zai Lab Soars 5.11% Intraday on FDA Fast Track Designation for Key ADC Drug

Stock Track
·
May 14

Zai Lab Grants 1.37 Million Share Options and 0.75 Million RSUs Under 2024 Equity Incentive Plan

Bulletin Express
·
May 12

Zai Lab Announces Grant of Stock Options and Restricted Stock Units

Stock News
·
May 12

Zai Lab grants 136,819 ADS share options under 2024 equity incentive plan at US$ 20.32

Reuters
·
May 12

Zai Lab Shares Surge Over 5% in Early Trading as Zoci Receives FDA Fast Track Designation

Stock News
·
May 12

Stock Track | ZAI LAB Soars 5.02% at Market Open Following 9.7% ADR Surge in US Trading

Stock Track
·
May 12

Hong Kong Stocks Open Higher, Tech and Gold Shares Gain; Kuaishou Surges Over 9%

Deep News
·
May 12

Asian Equities Traded in the US as American Depositary Receipts Open Week Lower in Monday Trading

MT Newswires Live
·
May 11

BRIEF-Zai Lab Receives U.S. FDA Fast Track Designation For Zocilurtatug Pelitecan (Zoci)

Reuters
·
May 11

Zai Lab says FDA grants Fast Track status to zoci for epNEC treatment

Reuters
·
May 11

Zai Lab Receives U.S. FDA Fast Track Designation for Zocilurtatug Pelitecan (Zoci), a Dll3-Targeting ADC, for Treatment of Extrapulmonary Neuroendocrine Carcinomas (Epnecs)

THOMSON REUTERS
·
May 11

HK Movers | Biotech Stocks Jump. InnoGen up over 44%; Clover Bio up over 11%; Junshi Bio up 9%; Laekna up 8%; Asymchem up over 3%; Tigermed up 2%

Tiger Newspress
·
May 11

Zai Lab's Innovative Pipeline Nears Key Milestones, Unveiling Three Core Strengths for Potential Rebound

Stock News
·
May 08

Zai Lab's Net Loss Widens in Q1

MT Newswires Live
·
May 08

BUZZ-Zai Lab HK shares fall to 5-week low on weak Q1 results

Reuters
·
May 08

Stock Track | Zai Lab Plummets 5.68% Intraday Following Q1 Results Showing Revenue Decline and Widening Losses

Stock Track
·
May 08